DaVita Inc. (DVA) News
Filter DVA News Items
DVA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DVA News Highlights
- DVA's 30 day story count now stands at 21.
- Over the past 13 days, DVA's stories per day has been in a clear uptrend, growing by about 0.51 per day.
- ABT, MDT and TOP are the most mentioned tickers in articles about DVA.
Latest DVA News From Around the Web
Below are the latest news stories about DAVITA INC that investors may wish to consider to help them evaluate DVA as an investment opportunity.
National Vision (EYE) Plans to Open New Stores Amid Macro WoesNational Vision (EYE) plans to continue executing core growth initiatives and further investing in competitive advantages. |
Abbott (ABT) Expands in Electrophysiology With New FDA NodAbbott (ABT) notes that using TactiFlex catheter can lead to reduced procedure times and better safety compared to the company's previous generation catheters. |
Hologic (HOLX) Gets FDA Nod for Multiplexed Respiratory TestHologic's (HOLX) Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is done using the fully-automated, high-throughput Panther Fusion system. |
Abbott's (ABT) Assert-IQ Cardiac Monitor Receives FDA ApprovalAbbott's (ABT) latest approval adds to its line-up of remote patient management and treatment tools that can support doctors more effectively. |
What's in the Cards for Medtronic (MDT) in Q4 Earnings?Medtronic (MDT) is likely to have prioritized its R&D investments, which might get reflected in the fiscal Q4 results. |
STERIS (STE) Continues to Face Dull Dental Sales, Margin WoesSTERIS (STE) competes for pharmaceutical, research and industrial customers against several large companies that have robust product portfolios and global reach. |
Veeva Systems' (VEEV) New Launch to Improve Patient OutcomesVeeva Systems' (VEEV) new offering is expected to facilitate effective engagement with customers and KOLs for improved patient journeys. |
Warren Buffett’s 2023 Portfolio: Top 15 Stock PicksIn this article, we discuss the top 15 stock picks from Warren Buffett’s latest portfolio. You can skip our discussion on Buffett’s recent investment decisions and go directly to Warren Buffett’s 2023 Portfolio: Top 5 Stock Picks. Berkshire Hathaway Inc. (NYSE:BRK-B) has been able to generate an average annualized return of 20% in the last […] |
Edwards Lifesciences' (EW) TAVR Study Outcome FavorableEdwards Lifesciences' (EW) latest findings of the study confirm the value of the Edwards Benchmark programme for standardizing clinical pathways for patients undergoing TAVR in Europe. |
Here's Why Investors Should Retain Omnicell (OMCL) Stock NowInvestors are optimistic about Omnicell (OMCL) on its strong execution of strategies, disciplined cost management and revenue timing. |